BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28370815)

  • 21. Power Doppler vascularity index for predicting malignancy of adnexal masses.
    Marret H; Sauget S; Giraudeau B; Body G; Tranquart F
    Ultrasound Obstet Gynecol; 2005 May; 25(5):508-13. PubMed ID: 15846763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transvaginal color Doppler assessment of venous flow in adnexal masses.
    Alcázar JL; López-García G
    Ultrasound Obstet Gynecol; 2001 May; 17(5):434-8. PubMed ID: 11380970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography.
    Zhang J; Mironov S; Hricak H; Ishill NM; Moskowitz CS; Soslow RA; Chi DS
    J Comput Assist Tomogr; 2008; 32(4):533-40. PubMed ID: 18664838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance evaluation of adnexal masses.
    Guerra A; Cunha TM; Félix A
    Acta Radiol; 2008 Jul; 49(6):700-9. PubMed ID: 18568564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
    Li HM; Qiang JW; Ma FH; Zhao SH
    J Ovarian Res; 2017 Jan; 10(1):4. PubMed ID: 28088245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.
    Shimada K; Matsumoto K; Mimura T; Ishikawa T; Munechika J; Ohgiya Y; Kushima M; Hirose Y; Asami Y; Iitsuka C; Miyamoto S; Onuki M; Tsunoda H; Matsuoka R; Ichizuka K; Sekizawa A
    Int J Clin Oncol; 2018 Jun; 23(3):514-521. PubMed ID: 29236181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.
    Marret H; Sauget S; Giraudeau B; Brewer M; Ranger-Moore J; Body G; Tranquart F
    J Ultrasound Med; 2004 Dec; 23(12):1629-39; quiz 1641-42. PubMed ID: 15557306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External validation of ADNEX MR SCORING system: a single-centre retrospective study.
    Sasaguri K; Yamaguchi K; Nakazono T; Mizuguchi M; Aishima S; Yokoyama M; Irie H
    Clin Radiol; 2019 Feb; 74(2):131-139. PubMed ID: 30514585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective external validation of the 'ovarian crescent sign' as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology.
    Van Holsbeke C; Van Belle V; Leone FP; Guerriero S; Paladini D; Melis GB; Greggi S; Fischerova D; De Jonge E; Neven P; Bourne T; Valentin L; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2010 Jul; 36(1):81-7. PubMed ID: 20217895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Value of DCE-MRI for Differentiating Malignant Adnexal Masses Compared with Contrast-enhanced-T1WI.
    Otani S; Kido A; Himoto Y; Sakata A; Otani T; Kuwahara R; Moribata Y; Nishio N; Yajima R; Nakao K; Kurata Y; Minamiguchi S; Mandai M; Nakamoto Y
    Magn Reson Med Sci; 2022 Oct; 21(4):599-607. PubMed ID: 34483226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort.
    Thomassin-Naggara I; Belghitti M; Milon A; Abdel Wahab C; Sadowski E; Rockall AG;
    Eur Radiol; 2021 Dec; 31(12):9588-9599. PubMed ID: 34041567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler sonography for the diagnosis of adnexal malignancies: results of a multicenter European study.
    Guerriero S; Alcazar JL; Coccia ME; Ajossa S; Scarselli G; Boi M; Gerada M; Melis GB
    J Ultrasound Med; 2002 Oct; 21(10):1105-11. PubMed ID: 12369665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced sonography in the examination of benign and malignant adnexal masses.
    Ordén MR; Gudmundsson S; Kirkinen P
    J Ultrasound Med; 2000 Nov; 19(11):783-8. PubMed ID: 11065267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
    Yuan Y; Kuai XP; Chen XS; Tao XF
    Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update.
    Forstner R; Thomassin-Naggara I; Cunha TM; Kinkel K; Masselli G; Kubik-Huch R; Spencer JA; Rockall A
    Eur Radiol; 2017 Jun; 27(6):2248-2257. PubMed ID: 27770228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of orbital masses by multiparametric MRI.
    Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
    Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indeterminate Adnexal Cysts at US: Prevalence and Characteristics of Ovarian Cancer.
    Sadowski EA; Paroder V; Patel-Lippmann K; Robbins JB; Barroilhet L; Maddox E; McMahon T; Sampene E; Wasnik AP; Blaty AD; Maturen KE
    Radiology; 2018 Jun; 287(3):1041-1049. PubMed ID: 29480762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DCE-MR imaging of orbital lesions: diagnostic performance of the tumor flow residence time τ calculated by a multi-compartmental pharmacokinetic tumor model based on individual factors.
    Erb-Eigner K; Asbach P; Ro SR; Haas M; Bertelmann E; Pietsch H; Schwenke C; Taupitz M; Denecke T; Hamm B; Lawaczeck R
    Acta Radiol; 2019 May; 60(5):643-652. PubMed ID: 30114927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.